Director Board Of Directors at Ypsilon Therapeutics
Houston, Texas, United States
Join Prog.AI to see contacts
Join Prog.AI to see contacts
Summary
👤
Senior
🎓
Top School
Dongxing Zha is a scientist-turned-biotech entrepreneur with over two decades of experience translating immunology and protein engineering into next-generation immuno-oncology therapies. He has founded and leads multiple companies—Ypsilon Therapeutics and Keyway TCR Discovery—focused on unlocking TCR-based and TCRm therapeutics for solid tumors through novel discovery and targeting platforms. His career spans scientific leadership roles at MD Anderson and Merck, where he led discovery programs in bispecifics, TCRs, and cell therapy targets, blending deep bench science with translational strategy. Known for building science-first, mission-driven teams, he excels at scaling early discoveries into viable clinical programs. Based in Houston, he pairs a PhD-trained research background with hands-on operational experience as CEO and board director. An understated strength is his ability to navigate both academic and industrial ecosystems to accelerate therapeutic innovation.
9 years of coding experience
12 years of employment as a software developer
Doctor of Philosophy - PhD, Microbiology, General, Doctor of Philosophy - PhD, Microbiology, General at Huazhong Agricultural University
Contributions:17 releases, 69 commits, 4 PRs in 4 months
animal-crossing-new-horizons
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.